수혈 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Blood Transfusion Diagnostics Market - Scope of Report

TMR's report on the global blood transfusion diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global blood transfusion diagnostics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global blood transfusion diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the blood transfusion diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global blood transfusion diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global blood transfusion diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global blood transfusion diagnostics market.

The report delves into the competitive landscape of the global blood transfusion diagnostics market. Key players operating in the global blood transfusion diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global blood transfusion diagnostics market profiled in this report.

Key Questions Answered in Global blood transfusion diagnostics Market Report:

• What is the sales/revenue generated by blood transfusion diagnostics across all regions during the forecast period?
• What are the opportunities in the global blood transfusion diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Blood Transfusion Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global blood transfusion diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global blood transfusion diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global blood transfusion diagnostics market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Epidemiology of Blood Disorders and Prevalence of Blood Transfusion Events
• 5.2. Blood Transfusion Products Pricing Analysis
• 5.3. Government Procurement Policies of Blood Transfusion Diagnostics
• 5.4. Key Industry Events (Partnerships, Collaborations, Product Approvals, Mergers and Acquisitions, Funding and investments)
• 5.5. Impact of COVID-19 Pandemic

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2020-2034
  • 6.3.1. Instruments
    • 6.3.1.1. Blood Grouping Instruments
    • 6.3.1.2. Others
  • 6.3.2. Kits and Reagents
    • 6.3.2.1. Blood Grouping Kits and Reagents
    • 6.3.2.2. Others
• 6.4. Market Attractiveness By Product Type

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Application

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Application, 2020-2034
  • 7.3.1. Blood Grouping
    • 7.3.1.1. ABO Blood Grouping
    • 7.3.1.2. Rh Blood Grouping
    • 7.3.1.3. Red Blood Cell Antibody Screening
    • 7.3.1.4. Extended Phenotyping
    • 7.3.1.5. Cross Matching Tests
  • 7.3.2. Disease Screening
    • 7.3.2.1. Molecular Disease Screening
    • 7.3.2.2. Serological Disease Screening
• 7.4. Market Attractiveness By Application

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By End-user

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By End-user, 2020-2034
  • 8.3.1. Blood Banks
  • 8.3.2. Blood Donation / Transfusion Centers
  • 8.3.3. Others
• 8.4. Market Attractiveness By End-user

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Country/Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Product Type, 2020-2034
  • 10.2.1. Instruments
    • 10.2.1.1. Blood Grouping Instruments
    • 10.2.1.2. Others
  • 10.2.2. Kits and Reagents
    • 10.2.2.1. Blood Grouping Kits and Reagents
    • 10.2.2.2. Others
• 10.3. Market Value Forecast By Application, 2020-2034
  • 10.3.1. Blood Grouping
    • 10.3.1.1. ABO Blood Grouping
    • 10.3.1.2. Rh Blood Grouping
    • 10.3.1.3. Red Blood Cell Antibody Screening
    • 10.3.1.4. Extended Phenotyping
    • 10.3.1.5. Cross Matching Tests
  • 10.3.2. Disease Screening
    • 10.3.2.1. Molecular Disease Screening
    • 10.3.2.2. Serological Disease Screening
• 10.4. Market Value Forecast By End-user, 2020-2034
  • 10.4.1. Blood Banks
  • 10.4.2. Blood Donation / Transfusion Centers
  • 10.4.3. Others
• 10.5. Market Value Forecast By Country, 2020-2034
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By Application
  • 10.6.3. By End-user
  • 10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product Type, 2020-2034
  • 11.2.1. Instruments
    • 11.2.1.1. Blood Grouping Instruments
    • 11.2.1.2. Others
  • 11.2.2. Kits and Reagents
    • 11.2.2.1. Blood Grouping Kits and Reagents
    • 11.2.2.2. Others
• 11.3. Market Value Forecast By Application, 2020-2034
  • 11.3.1. Blood Grouping
    • 11.3.1.1. ABO Blood Grouping
    • 11.3.1.2. Rh Blood Grouping
    • 11.3.1.3. Red Blood Cell Antibody Screening
    • 11.3.1.4. Extended Phenotyping
    • 11.3.1.5. Cross Matching Tests
  • 11.3.2. Disease Screening
    • 11.3.2.1. Molecular Disease Screening
    • 11.3.2.2. Serological Disease Screening
• 11.4. Market Value Forecast By End-user, 2020-2034
  • 11.4.1. Blood Banks
  • 11.4.2. Blood Donation / Transfusion Centers
  • 11.4.3. Others
• 11.5. Market Value Forecast By Country, 2020-2034
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By Application
  • 11.6.3. By End-user
  • 11.6.4. By Country

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2020-2034
  • 12.2.1. Instruments
    • 12.2.1.1. Blood Grouping Instruments
    • 12.2.1.2. Others
  • 12.2.2. Kits and Reagents
    • 12.2.2.1. Blood Grouping Kits and Reagents
    • 12.2.2.2. Others
• 12.3. Market Value Forecast By Application, 2020-2034
  • 12.3.1. Blood Grouping
    • 12.3.1.1. ABO Blood Grouping
    • 12.3.1.2. Rh Blood Grouping
    • 12.3.1.3. Red Blood Cell Antibody Screening
    • 12.3.1.4. Extended Phenotyping
    • 12.3.1.5. Cross Matching Tests
  • 12.3.2. Disease Screening
    • 12.3.2.1. Molecular Disease Screening
    • 12.3.2.2. Serological Disease Screening
• 12.4. Market Value Forecast By End-user, 2020-2034
  • 12.4.1. Blood Banks
  • 12.4.2. Blood Donation / Transfusion Centers
  • 12.4.3. Others
• 12.5. Market Value Forecast By Country, 2020-2034
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By Application
  • 12.6.3. By End-user
  • 12.6.4. By Country

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2020-2034
  • 13.2.1. Instruments
    • 13.2.1.1. Blood Grouping Instruments
    • 13.2.1.2. Others
  • 13.2.2. Kits and Reagents
    • 13.2.2.1. Blood Grouping Kits and Reagents
    • 13.2.2.2. Others
• 13.3. Market Value Forecast By Application, 2020-2034
  • 13.3.1. Blood Grouping
    • 13.3.1.1. ABO Blood Grouping
    • 13.3.1.2. Rh Blood Grouping
    • 13.3.1.3. Red Blood Cell Antibody Screening
    • 13.3.1.4. Extended Phenotyping
    • 13.3.1.5. Cross Matching Tests
  • 13.3.2. Disease Screening
    • 13.3.2.1. Molecular Disease Screening
    • 13.3.2.2. Serological Disease Screening
• 13.4. Market Value Forecast By End-user, 2020-2034
  • 13.4.1. Blood Banks
  • 13.4.2. Blood Donation / Transfusion Centers
  • 13.4.3. Others
• 13.5. Market Value Forecast By Country, 2020-2034
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By Application
  • 13.6.3. By End-user
  • 13.6.4. By Country

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2020-2034
  • 14.2.1. Instruments
    • 14.2.1.1. Blood Grouping Instruments
    • 14.2.1.2. Others
  • 14.2.2. Kits and Reagents
    • 14.2.2.1. Blood Grouping Kits and Reagents
    • 14.2.2.2. Others
• 14.3. Market Value Forecast By Application, 2020-2034
  • 14.3.1. Blood Grouping
    • 14.3.1.1. ABO Blood Grouping
    • 14.3.1.2. Rh Blood Grouping
    • 14.3.1.3. Red Blood Cell Antibody Screening
    • 14.3.1.4. Extended Phenotyping
    • 14.3.1.5. Cross Matching Tests
  • 14.3.2. Disease Screening
    • 14.3.2.1. Molecular Disease Screening
    • 14.3.2.2. Serological Disease Screening
• 14.4. Market Value Forecast By End-user, 2020-2034
  • 14.4.1. Blood Banks
  • 14.4.2. Blood Donation / Transfusion Centers
  • 14.4.3. Others
• 14.5. Market Value Forecast By Country, 2020-2034
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product Type
  • 14.6.2. By Application
  • 14.6.3. By End-user
  • 14.6.4. By Country

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Company Profiles
  • 15.2.1. Grifols, S.A.
    • 15.2.1.1. Company Overview
    • 15.2.1.2. Financial Overview
    • 15.2.1.3. Product Portfolio
    • 15.2.1.4. Business Strategies
    • 15.2.1.5. Recent Developments
  • 15.2.2. Werfen, S.A.
    • 15.2.2.1. Company Overview
    • 15.2.2.2. Financial Overview
    • 15.2.2.3. Product Portfolio
    • 15.2.2.4. Business Strategies
    • 15.2.2.5. Recent Developments
  • 15.2.3. QuidelOrtho Corporation
    • 15.2.3.1. Company Overview
    • 15.2.3.2. Financial Overview
    • 15.2.3.3. Product Portfolio
    • 15.2.3.4. Business Strategies
    • 15.2.3.5. Recent Developments
  • 15.2.4. Abbott
    • 15.2.4.1. Company Overview
    • 15.2.4.2. Financial Overview
    • 15.2.4.3. Product Portfolio
    • 15.2.4.4. Business Strategies
    • 15.2.4.5. Recent Developments
  • 15.2.5. Bio-Rad Laboratories Inc.
    • 15.2.5.1. Company Overview
    • 15.2.5.2. Financial Overview
    • 15.2.5.3. Product Portfolio
    • 15.2.5.4. Business Strategies
    • 15.2.5.5. Recent Developments
  • 15.2.6. F. Hoffman La Roche Ltd.
    • 15.2.6.1. Company Overview
    • 15.2.6.2. Financial Overview
    • 15.2.6.3. Product Portfolio
    • 15.2.6.4. Business Strategies
    • 15.2.6.5. Recent Developments
  • 15.2.7. AliveDx Holdings Finance Company Ltd
    • 15.2.7.1. Company Overview
    • 15.2.7.2. Financial Overview
    • 15.2.7.3. Product Portfolio
    • 15.2.7.4. Business Strategies
    • 15.2.7.5. Recent Developments
  • 15.2.8. BAG Diagnostics GmbH
    • 15.2.8.1. Company Overview
    • 15.2.8.2. Financial Overview
    • 15.2.8.3. Product Portfolio
    • 15.2.8.4. Business Strategies
    • 15.2.8.5. Recent Developments
  • 15.2.9. Diasorin S.p.A.
    • 15.2.9.1. Company Overview
    • 15.2.9.2. Financial Overview
    • 15.2.9.3. Product Portfolio
    • 15.2.9.4. Business Strategies
    • 15.2.9.5. Recent Developments
  • 15.2.10. Prestige Diagnostics U.K. Ltd.
    • 15.2.10.1. Company Overview
    • 15.2.10.2. Financial Overview
    • 15.2.10.3. Product Portfolio
    • 15.2.10.4. Business Strategies
    • 15.2.10.5. Recent Developments
  • 15.2.11. Atlas Medical GmbH
    • 15.2.11.1. Company Overview
    • 15.2.11.2. Financial Overview
    • 15.2.11.3. Product Portfolio
    • 15.2.11.4. Business Strategies
    • 15.2.11.5. Recent Developments
  • 15.2.12. Lorne Laboratories Limited
    • 15.2.12.1. Company Overview
    • 15.2.12.2. Financial Overview
    • 15.2.12.3. Product Portfolio
    • 15.2.12.4. Business Strategies
    • 15.2.12.5. Recent Developments